Evan B. Cunningham

5.8k total citations · 3 hit papers
62 papers, 3.0k citations indexed

About

Evan B. Cunningham is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Evan B. Cunningham has authored 62 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Epidemiology, 47 papers in Hepatology and 15 papers in Infectious Diseases. Recurrent topics in Evan B. Cunningham's work include Hepatitis C virus research (47 papers), HIV, Drug Use, Sexual Risk (35 papers) and Hepatitis B Virus Studies (23 papers). Evan B. Cunningham is often cited by papers focused on Hepatitis C virus research (47 papers), HIV, Drug Use, Sexual Risk (35 papers) and Hepatitis B Virus Studies (23 papers). Evan B. Cunningham collaborates with scholars based in Australia, United Kingdom and United States. Evan B. Cunningham's co-authors include Jason Grebely, Gregory J. Dore, Matthew Hickman, Louisa Degenhardt, Peter Vickerman, Samantha Colledge‐Frisby, Janni Leung, Amy Peacock, Sarah Larney and Michael T. Lynskey and has published in prestigious journals such as Journal of Clinical Microbiology, The Journal of Infectious Diseases and Journal of Hepatology.

In The Last Decade

Evan B. Cunningham

58 papers receiving 2.9k citations

Hit Papers

Global prevalence of injecting drug use and sociodemograp... 2017 2026 2020 2023 2017 2017 2023 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Evan B. Cunningham Australia 24 2.6k 1.7k 937 565 232 62 3.0k
Norah Palmateer United Kingdom 24 2.1k 0.8× 1.1k 0.7× 782 0.8× 788 1.4× 177 0.8× 54 2.3k
Adam Trickey United Kingdom 19 1.8k 0.7× 1.2k 0.7× 745 0.8× 395 0.7× 177 0.8× 67 2.3k
Kostyantyn Dumchev Ukraine 15 1.6k 0.6× 743 0.4× 817 0.9× 458 0.8× 183 0.8× 55 1.9k
Paula J. Lum United States 29 2.3k 0.9× 998 0.6× 1.1k 1.1× 879 1.6× 484 2.1× 77 3.0k
Avril Taylor United Kingdom 28 2.3k 0.9× 1.0k 0.6× 590 0.6× 850 1.5× 493 2.1× 78 2.8k
Magdalena Harris United Kingdom 28 1.5k 0.6× 711 0.4× 432 0.5× 696 1.2× 309 1.3× 85 2.1k
Danielle Horyniak Australia 17 1.4k 0.5× 831 0.5× 395 0.4× 373 0.7× 270 1.2× 51 2.0k
Ashly E. Jordan United States 20 1.3k 0.5× 834 0.5× 481 0.5× 472 0.8× 146 0.6× 63 1.6k
Jenny Iversen Australia 23 1.2k 0.5× 585 0.3× 496 0.5× 344 0.6× 179 0.8× 51 1.4k
Alice Asher United States 18 1.1k 0.4× 542 0.3× 559 0.6× 480 0.8× 179 0.8× 41 1.5k

Countries citing papers authored by Evan B. Cunningham

Since Specialization
Citations

This map shows the geographic impact of Evan B. Cunningham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evan B. Cunningham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evan B. Cunningham more than expected).

Fields of papers citing papers by Evan B. Cunningham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evan B. Cunningham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evan B. Cunningham. The network helps show where Evan B. Cunningham may publish in the future.

Co-authorship network of co-authors of Evan B. Cunningham

This figure shows the co-authorship network connecting the top 25 collaborators of Evan B. Cunningham. A scholar is included among the top collaborators of Evan B. Cunningham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evan B. Cunningham. Evan B. Cunningham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lafferty, Lise, Carla Treloar, Evan B. Cunningham, et al.. (2025). Acceptability of hepatitis C testing using point-of-care testing and dried blood spot collection among people at risk of hepatitis C infection. International Journal of Drug Policy. 137. 104720–104720. 1 indexed citations
2.
Artenie, Andreea Adelina, Adam Trickey, Katharine J Looker, et al.. (2025). Global, regional, and national estimates of hepatitis C virus (HCV) infection incidence among people who inject drugs and number of new annual HCV infections attributable to injecting drug use: a multi-stage analysis. ˜The œLancet. Gastroenterology & hepatology. 10(4). 315–331. 1 indexed citations
3.
Ryan, Hannah, Gregory J. Dore, Jason Grebely, et al.. (2024). Hepatitis C treatment outcome among people in prison: The SToP‐C study. Liver International. 44(11). 2996–3007. 2 indexed citations
4.
Cunningham, Evan B., et al.. (2024). From pathology to pleasure: Reframing mechanistic studies on same-sex sexual behavior in primates. Hormones and Behavior. 160. 105476–105476. 4 indexed citations
5.
Shih, Sophy, Tanya Applegate, Jisoo A. Kwon, et al.. (2024). Impact of simplified HCV diagnostic strategies on the HCV epidemic among men who have sex with men in the era of HIV oral pre‐exposure prophylaxis in Taiwan: a modelling study. Journal of the International AIDS Society. 27(5). e26251–e26251. 1 indexed citations
6.
MacDonald, C., Lucy Thi Tran, Evan B. Cunningham, et al.. (2024). Interventions to reduce harms related to drug use among people who experience incarceration: systematic review and meta-analysis. The Lancet Public Health. 9(9). e684–e699. 5 indexed citations
7.
Barbieri, Sebastiano, Evan B. Cunningham, Marc van der Valk, et al.. (2023). Sexual and drug use risk behaviour trajectories among people treated for recent HCV infection: the REACT study. Journal of the International AIDS Society. 26(9). e26168–e26168. 3 indexed citations
8.
Grebely, Jason, Anna Conway, Evan B. Cunningham, et al.. (2023). Single-visit hepatitis C point-of-care testing, linkage to nursing care, and peer-supported treatment among people with recent injecting drug use at a peer-led needle and syringe program: The TEMPO Pilot Study. International Journal of Drug Policy. 114. 103982–103982. 23 indexed citations
9.
Hajarizadeh, Behzad, Marianne Byrne, Jason Grebely, et al.. (2023). Incidence of hepatitis C virus infection in the prison setting: The SToP‐C study. Journal of Viral Hepatitis. 31(1). 21–34. 4 indexed citations
10.
Shih, Sophy, Qinglu Cheng, Heather Valerio, et al.. (2023). Optimizing point-of-care testing strategies for diagnosis and treatment of hepatitis C virus infection in Australia: a model-based cost-effectiveness analysis. The Lancet Regional Health - Western Pacific. 36. 100750–100750. 15 indexed citations
11.
Colledge‐Frisby, Samantha, Paige Webb, Jason Grebely, et al.. (2023). Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review. The Lancet Global Health. 11(5). e673–e683. 60 indexed citations
13.
Degenhardt, Louisa, Paige Webb, Samantha Colledge‐Frisby, et al.. (2023). Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review. The Lancet Global Health. 11(5). e659–e672. 109 indexed citations breakdown →
14.
Cunningham, Evan B., Alice Wheeler, Behzad Hajarizadeh, et al.. (2022). Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysis. International Journal of Drug Policy. 111. 103917–103917. 31 indexed citations
15.
Cunningham, Evan B., et al.. (2021). Reinfection following successful direct-acting antiviral therapy for HCV infection among people attending an inner-city community health centre in Victoria, Canada. International Journal of Drug Policy. 96. 103418–103418. 5 indexed citations
16.
Hajarizadeh, Behzad, Evan B. Cunningham, Heather Valerio, et al.. (2019). Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis. Journal of Hepatology. 72(4). 643–657. 114 indexed citations
17.
Colledge‐Frisby, Samantha, Janni Leung, Sarah Larney, et al.. (2019). Frequency of injecting among people who inject drugs: A systematic review and meta-analysis. International Journal of Drug Policy. 76. 102619–102619. 3 indexed citations
18.
Grebely, Jason, Sarah Larney, Amy Peacock, et al.. (2018). Global, regional, and country‐level estimates of hepatitis C infection among people who have recently injected drugs. Addiction. 114(1). 150–166. 174 indexed citations
19.
Bajis, Sahar, Gregory J. Dore, Behzad Hajarizadeh, et al.. (2017). Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: A systematic review. International Journal of Drug Policy. 47. 34–46. 149 indexed citations
20.
Lamoury, F., Behzad Hajarizadeh, Evan B. Cunningham, et al.. (2017). Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapse. Journal of Clinical Virology. 92. 32–38. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026